Coronary Stents Market Size By Product (Bare Metal Stents, Drug Eluting Stents, Bioresorbable Vascular Scaffold), By End-use (Hospitals, Cardiac Centers, Ambulatory Surgical Centers), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, G

Coronary Stents Market Size By Product (Bare Metal Stents, Drug Eluting Stents, Bioresorbable Vascular Scaffold), By End-use (Hospitals, Cardiac Centers, Ambulatory Surgical Centers), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032

Coronary Stents Market will depict a noticeable growth during 2023-2032, owing to rising demand for minimally invasive procedures. There has been a rising inclination towards minimally invasive surgeries owing to the constant technological innovations in cardiac surgical procedures.

A coronary stent is used to treat blocked or restricted coronary arteries. It is also used to enhance blood flow right after a heart attack. Currently, all angioplasty operations use coronary stents. As per credible reports, more than 2 million people get stent every year.

The key players operating in the industry are also focusing on developing various minimally invasive coronary stents to satisfy the rising patient needs, thus fostering the market expansion. To cite an instance, in 2023, Abbott announced entering into a definitive agreement to acquire CSI. CSI develops and commercializes products for treating peripheral and coronary vascular disease. The latest acquisition will enable Abbott to add innovative, complementary technologies to its leading vascular device offerings.

Overall, the coronary stents industry is segmented in terms of product, end-use, and region.

Based on the product, the bare metal stent segment is anticipated to register sturdy growth through 2032. The segmental growth can be credited to the growing licensed use of the bare-metal stent in cardiac arteries. Besides, these stents also reduce the risk of stent thrombosis and abrupt vessel closure, lowering the target lesion revascularization rate. Various studies involving bare stents are underway. In 2023, recent research revealed that the combination of double bare stent and endobiliary radiofrequency ablation could support ingrowth reduction.

By end-use, the ambulatory surgical center segment is anticipated to be valued at over USD 989 million by 2032. An increasing number of patients visiting ambulatory surgical centers for stent implantation surgeries will bolster the market growth in the coming years. In addition, the presence of advanced and innovative facilities in ambulatory surgical centers and single-day cardiovascular surgery will increase patient preference.

In terms of the regional context, the North America coronary stents industry held over 25.5% of the market in 2022 and is expected to register notable gains through 2032. The regional market growth will come from the rising strategic initiatives by leading industry players including the launch of next-generation coronary stents to cater to the rising patient demand. Besides, the increasing number of cardiac patients will support the overall regional outlook in the coming future. According to credible reports, approximately 600,000 coronary stents are instilled annually during PCIs (percutaneous coronary interventions) in the United States.